Alaunos Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRT and other ETFs, options, and stocks.About TCRT
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy.
TCRT Key Statistics
Stock Snapshot
With a market cap of 2.39M, Alaunos Therapeutics(TCRT) trades at $0.82. The stock has a price-to-earnings ratio of -0.42.
During the trading session on 2026-10-03, Alaunos Therapeutics(TCRT) shares reached a daily high of $0.92 and a low of $0.82. At a current price of $0.82, the stock is +0.4% higher than the low and still -11.3% under the high.
Trading activity shows a volume of 86.44K, compared to an average daily volume of 202.1K.
The stock's 52-week range extends from a low of $0.82 to a high of $4.59.
The stock's 52-week range extends from a low of $0.82 to a high of $4.59.
Analyst ratings
67%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.